42 results Loyalty rebate scheme 'saved' by pharma company's market misconceptions The UK Competition and Markets Authority (CMA) recently closed its investigation into a discount scheme by dominant pharma company Merck Sharp & Dohme (MSD) aimed at preventing the National Health Service (NHS) from switching to competing biosimilars. Wetsvoorstel tot implementatie Vierde Spoorwegpakket op 29 januari 2019 aangenomen Eerder schreven wij een blogbericht over de implementatie van het zogenaamde 'Vierde Spoorwegpakket'. In navolging van de Tweede Kamer (9 oktober 2018) heeft de Eerste Kamer het daartoe strekkende wetsvoorstel op 29 januari 2019 aangenomen. Swifter merger clearance and shorter merger filings in Belgium Companies can expect swifter merger clearance and simpler filing rules in Belgium. The Belgian Competition Authority has published a communication with additional rules concerning the simplified procedure for certain types of concentrations. Who is a consumer? The dynamic approach to the concept of 'consumer' under the Brussels I Regulation On 25 January 2018, the European Court of Justice ("ECJ") rendered a preliminary ruling in a case between Austrian citizen Maximilian Schrems and online social network Facebook. The ruling is important for two reasons. Gotta catch ‘em all? Upward referral of ‘killer acquisitions’ upheld Companies involved in intended or completed M&A transactions falling below EU and national merger notification thresholds should beware that their deals may still catch the European Commission’s eye. Een inbreuk op de AVG geeft niet zonder meer recht op schadevergoeding: Europese ontwikkelingen De Algemene Verordening Gegevensbescherming (de “AVG”) is één van de meest ingrijpende ontwikkelingen binnen de Europese datastrategie van de afgelopen jaren en nog steeds volop in ontwikkeling. Pagination Previous page Page 1 Page 2 Current page 3
Loyalty rebate scheme 'saved' by pharma company's market misconceptions The UK Competition and Markets Authority (CMA) recently closed its investigation into a discount scheme by dominant pharma company Merck Sharp & Dohme (MSD) aimed at preventing the National Health Service (NHS) from switching to competing biosimilars.
Wetsvoorstel tot implementatie Vierde Spoorwegpakket op 29 januari 2019 aangenomen Eerder schreven wij een blogbericht over de implementatie van het zogenaamde 'Vierde Spoorwegpakket'. In navolging van de Tweede Kamer (9 oktober 2018) heeft de Eerste Kamer het daartoe strekkende wetsvoorstel op 29 januari 2019 aangenomen.
Swifter merger clearance and shorter merger filings in Belgium Companies can expect swifter merger clearance and simpler filing rules in Belgium. The Belgian Competition Authority has published a communication with additional rules concerning the simplified procedure for certain types of concentrations.
Who is a consumer? The dynamic approach to the concept of 'consumer' under the Brussels I Regulation On 25 January 2018, the European Court of Justice ("ECJ") rendered a preliminary ruling in a case between Austrian citizen Maximilian Schrems and online social network Facebook. The ruling is important for two reasons.
Gotta catch ‘em all? Upward referral of ‘killer acquisitions’ upheld Companies involved in intended or completed M&A transactions falling below EU and national merger notification thresholds should beware that their deals may still catch the European Commission’s eye.
Een inbreuk op de AVG geeft niet zonder meer recht op schadevergoeding: Europese ontwikkelingen De Algemene Verordening Gegevensbescherming (de “AVG”) is één van de meest ingrijpende ontwikkelingen binnen de Europese datastrategie van de afgelopen jaren en nog steeds volop in ontwikkeling.